|
Re: Market Sentiment
|
1
|
Resverlogix Corp.
|
Sep 18, 2019 03:26PM
|
|
Re: Market Woes
|
1
|
Resverlogix Corp.
|
Apr 30, 2022 07:42PM
|
|
Re: Market Woes
|
2
|
Resverlogix Corp.
|
May 01, 2022 10:09AM
|
|
Re: Market Woes
|
4
|
Resverlogix Corp.
|
May 01, 2022 07:57PM
|
|
Re: May thru October 2020
|
3
|
Resverlogix Corp.
|
Apr 21, 2020 10:44AM
|
|
Re: Maybe So
|
2
|
Resverlogix Corp.
|
Aug 18, 2020 04:40PM
|
|
Re: Maybe timing is everything…
|
3
|
Resverlogix Corp.
|
Jun 04, 2023 09:47AM
|
|
Re: Maybe timing is everything…
|
1
|
Resverlogix Corp.
|
Jun 05, 2023 08:09AM
|
|
Re: Maybe timing is everything…
|
1
|
Resverlogix Corp.
|
Jun 05, 2023 08:38AM
|
|
Re: maybe Zen will go first?
|
2
|
Resverlogix Corp.
|
May 04, 2020 01:39PM
|
|
Re: maybe Zen will go first?
|
1
|
Resverlogix Corp.
|
May 05, 2020 10:14AM
|
|
Re: maybe Zen will go first?
|
1
|
Resverlogix Corp.
|
May 05, 2020 05:14PM
|
|
Re: maybe Zen will go first?
|
1
|
Resverlogix Corp.
|
May 05, 2020 06:50PM
|
|
Re: MD&A
|
1
|
Resverlogix Corp.
|
Sep 14, 2020 12:13PM
|
|
Re: Meaning of MACE in the BTD
|
1
|
Resverlogix Corp.
|
Feb 19, 2020 08:36AM
|
|
Re: Meanwhile back at the outhouse, things are piling up....no tweet about the AGM
|
2
|
Resverlogix Corp.
|
Aug 24, 2019 12:45PM
|
|
Re: Merck's PIII Prostate trial, not the one with ZEN-3694, is halted for not showing improvement vs control
|
1
|
Zenith Epigenetics
|
Jan 27, 2023 09:55AM
|
|
Re: Merck's PIII Prostate trial, not the one with ZEN-3694, is halted for not showing improvement vs control
|
1
|
Zenith Epigenetics
|
Jan 27, 2023 10:49AM
|
|
Re: Merck's PIII Prostate trial, not the one with ZEN-3694, is halted for not showing improvement vs control
|
1
|
Zenith Epigenetics
|
Jan 26, 2023 06:12AM
|
|
Re: Merck's PIII Prostate trial, not the one with ZEN-3694, is halted for not showing improvement vs control
|
3
|
Zenith Epigenetics
|
Jan 26, 2023 02:04PM
|
